-
公开(公告)号：SG11202108141VA
公开(公告)日：2021-08-30
申请号：SG11202108141V
申请日：2020-01-30
Applicant: LAVA THERAPEUTICS B V
Inventor： VAN DER VLIET JOHANNES JELLE , DE WEERDT IRIS , DE GRUIJL TANJA DENISE , PARREN PAUL , KATER ARON PHILIP , SCHEFFER GEORGE LODEWIJK
Abstract: The present invention relates to novel antibodies capable of binding human CD40 and to novel multispecific antibodies capable of binding human CD40 and capable of binding a human Vγ9Vδ2 T cell receptor. The invention further relates to pharmaceutical compositions comprising the antibodies of the invention and to uses of the antibodies of the invention for medical treatment.
-
公开(公告)号：CA3128148A1
公开(公告)日：2020-08-06
申请号：CA3128148
申请日：2020-01-30
Applicant: LAVA THERAPEUTICS B V
Inventor： VAN DER VLIET JOHANNES JELLE , DE WEERDT IRIS , DE GRUIJL TANJA DENISE , PARREN PAUL , KATER ARON PHILIP , SCHEFFER GEORGE LODEWIJK
Abstract: The present invention relates to novel antibodies capable of binding human CD40 and to novel multispecific antibodies capable of binding human CD40 and capable of binding a human V?9Vd2 T cell receptor. The invention further relates to pharmaceutical compositions comprising the antibodies of the invention and to uses of the antibodies of the invention for medical treatment.
-
公开(公告)号：BR112021015238A2
公开(公告)日：2022-02-15
申请号：BR112021015238
申请日：2020-01-30
Applicant: LAVA THERAPEUTICS B V
Inventor： ARON PHILIP KATER , GEORGE LODEWIJK SCHEFFER , IRIS DE WEERDT , JOHANNES JELLE VAN DER VLIET , PARREN PAUL , TANJA DENISE DE GRUIJL
Abstract: novos anticorpos de ligação a cd40. a presente invenção se refere a novos anticorpos capazes de se ligar a cd40 humano e a novos anticorpos multiespecíficos capazes de se ligar a cd40 humano e de se ligar a um receptor de células t v¿9v¿2 humano. a invenção também se refere a composições farmacêuticas que compreendem os anticorpos da invenção e aos usos dos anticorpos da invenção para tratamento médico.
-
-
Search Results
3
records
(took 0.021 seconds)
